ArticleEuropean radiology2022

Validating the screening criteria for bone metastases in treatment-naïve unfavorable intermediate and high-risk prostate cancer - the prevalence and location of bone- and lymph node metastases.

Erik Rud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.